United States Biotechnology & Medical Research

Qualigen Therapeutics Inc (QLGN)

Track

Ticker: QLGN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Qualigen Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 22 Jun 2022
Value US$1,047,190.79 | Price 476.85 | Shares 67,829 (-14.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-06-22 2022-06-22 B Purchase
1.3
Poirier Michael S.

Chairman and CEO

Executive Director
67,829 -14.3%
476.85
US$1,047,191 		67,829 -14.3% 476.85 US$1,047,191
2022-06-15 2022-06-14 B Purchase
1.1
BROIDRICK AMY S.

President/CSO

Executive Director
55,156 +42.8%
234.32
US$4,104,335 		55,156 +42.8% 234.32 US$4,104,335
2021-04-26 2021-04-26 B Purchase
1.1
BROIDRICK AMY S.

EVP, Chief Strategy Officer

Executive Director
47,268 +24.4%
439.61
US$4,986,373 		47,268 +24.4% 439.61 US$4,986,373
2021-04-21 2021-04-20 B Purchase
1.3
Poirier Michael S.

Chairman, CEO & President

Executive Director
11,005 +inf%
1.80
US$19,809 		11,005 +inf% 1.80 US$19,809
2021-04-19 2021-04-16 B Purchase
0.9
Lotz Christopher L.

Vice President of Finance, CFO

Officer
2,700 +27.4%
1.86
US$5,022 		2,700 +27.4% 1.86 US$5,022
2020-12-30 2020-12-29 B Purchase
2.0
Kruger Kurt H
Non-Executive Director
4,000 +66.7%
2.94
US$11,740 		4,000 +66.7% 2.94 US$11,740
2020-11-23 2020-11-23 B Purchase
2.0
Kruger Kurt H
Non-Executive Director
4,600 +328.6%
3.46
US$15,925 		4,600 +328.6% 3.46 US$15,925
2020-11-23 2020-11-20 B Purchase
2.0
Kruger Kurt H
Non-Executive Director
1,400 +inf%
3.55
US$4,969 		1,400 +inf% 3.55 US$4,969
2020-03-16 2020-03-12 S Sale
2.1
Doyle Noah
Non-Executive Director
500,000 -41.5%
0.22
US$110,000 		500,000 -41.5% 0.22 US$110,000
2020-03-13 2020-03-04 S Sale
3.3
Ritter Ira E.

COB, CSO

Executive Director
18,750 -18.7%
0.38
US$7,042 		18,750 -18.7% 0.38 US$7,042
2020-03-13 2020-03-04 S Sale
3.3
Ritter Andrew J

CEO and President

Executive Director
18,750 -18.7%
0.38
US$7,042 		18,750 -18.7% 0.38 US$7,042
2018-08-20 2018-08-17 B Purchase FOEHR MATTHEW W Non-Executive Director
19,751 +56.4%
2.04
US$40,292 		19,751 +56.4% 2.04 US$40,292
2017-10-27 2017-10-03 B Purchase Javelin Venture Partners, L.P. Large shareholder
5,000,000
0.00
US$0 		5,000,000 0.00 US$0
2017-10-27 2017-10-03 B Purchase Doyle Noah Non-Executive Director Large shareholder
5,000,000
0.00
US$0 		5,000,000 0.00 US$0
2017-10-27 2017-10-03 B Purchase Ritter Ira E.

Exec. Chairman, CSO

Executive Director Large shareholder
187,500
0.00
US$0 		187,500 0.00 US$0
2017-10-27 2017-10-03 B Purchase Ritter Andrew J

President

Officer Large shareholder
187,500
0.00
US$0 		187,500 0.00 US$0
2017-05-18 2017-05-18 B Purchase FOEHR MATTHEW W Non-Executive Director
18,000 +105.9%
0.62
US$11,155 		18,000 +105.9% 0.62 US$11,155
2017-05-12 2017-05-11 B Purchase Step Michael D

CEO

Executive Director
13,000 +35.1%
0.62
US$8,007 		13,000 +35.1% 0.62 US$8,007
2017-02-28 2017-02-27 B Purchase Step Michael D

CEO

Executive Director
8,000 +27.6%
2.65
US$21,200 		8,000 +27.6% 2.65 US$21,200
2017-02-28 2017-02-27 B Purchase Step Michael D

CEO

Executive Director
2,000 +7.4%
2.64
US$5,280 		2,000 +7.4% 2.64 US$5,280
2016-02-24 2016-02-22 B Purchase Ritter Andrew J

President

Executive Director Large shareholder
6,250 +inf%
1.60
US$10,000 		6,250 +inf% 1.60 US$10,000
2016-02-24 2016-02-22 B Purchase Ritter Ira E.

Exec. Chairman, CSO

Executive Director Large shareholder
6,250 +inf%
1.60
US$10,000 		6,250 +inf% 1.60 US$10,000
2016-01-11 2016-01-08 B Purchase FOEHR MATTHEW W Non-Executive Director
13,000 +325.0%
1.64
US$21,320 		13,000 +325.0% 1.64 US$21,320
2016-01-08 2016-01-07 B Purchase Step Michael D

CEO

Executive Director
27,000 +inf%
1.48
US$39,960 		27,000 +inf% 1.48 US$39,960
2015-06-25 2015-06-24 B Purchase Javelin Venture Partners, L.P. Large shareholder
800,000 +inf%
5.00
US$4,000,000 		800,000 +inf% 5.00 US$4,000,000
2015-06-25 2015-06-24 B Purchase Doyle Noah Non-Executive Director
800,000 +inf%
5.00
US$4,000,000 		800,000 +inf% 5.00 US$4,000,000
2015-06-25 2015-06-24 B Purchase PROEHL GERALD T Non-Executive Director
50,000 +inf%
5.00
US$250,000 		50,000 +inf% 5.00 US$250,000
2015-06-25 2015-06-24 B Purchase FOEHR MATTHEW W Non-Executive Director
4,000 +inf%
5.00
US$20,000 		4,000 +inf% 5.00 US$20,000
Explore more

More insider trading research around Qualigen Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America